Share on LinkedInShare on LinkedIn

ARTICLE · 09 SEPTEMBER 2025

Impact Of GST Rate Changes On The Health And Pharma Sector

Lakshmikumaran & Sridharan
Lakshmikumaran & Sridharan
Contributor
Lakshmikumaran & Sridharan

Lakshmikumaran & Sridharan

Lakshmikumaran & Sridharan (LKS) is a premier full-service Indian law firm specializing in areas...

View firm profile
Explore more from Lakshmikumaran & Sridharan

The GST Council in 56th meeting held in New Delhi on 03.09.2025 introduced significant reforms aimed at making healthcare more affordable and accessible to common man.

IndiaTax
Lakshmikumaran & Sridharan Attorneys
Lakshmikumaran & Sridharan Attorneys
Author LinkedIn connections

The GST Council in 56th meeting held in New Delhi on 03.09.2025 introduced significant reforms aimed at making healthcare more affordable and accessible to common man. The changes reflect a citizen-centric approach, with a strong emphasis on public health and the pharmaceutical sector and to make insurance services accessible to all. The changes will be effective from 22.09.2025. The changes and its impact from the lens of the pharma and medical devices industry and insurance industry is captured below.

Impact on pharma and medical devices sector:

  • Future pricing – going forward basis: Pricing of goods shall undergo a change to reflect on the reduction in GST rate. Appropriate GST rate as per provisions relating to change in rate of GST shall be followed. Although anti-profiteering has not been revived, expectations of the Government including based on historical data and previous experiences with such rate reduction and instructions from National

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from